Pricing Log in Create free account

Cogent Biosciences, Inc. (COGT) vs Travere Therapeutics, Inc. (TVTX)

Cogent Biosciences, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. and Travere Therapeutics, Inc. are of similar size ($5.1B and $5.0B). Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against 77.1%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −7.35%) and the higher return on invested capital (0.00% vs −18.3%). Across the 18 metrics below, Cogent Biosciences, Inc. leads on 10 and Travere Therapeutics, Inc. on 8.

Valuation

Metric COGT TVTX Biotechnology median
P/E n/m n/m 8.50
P/S 217.97 7.84 9.71
P/B 10.79 189.16 2.13
Price to free cash flow n/m 320.51 20.82
EV/EBITDA n/m 236.26 0.64
EV/Sales 193.41 8.04 9.21
Earnings yield (7.32%) (0.91%) (33.15%)
Free cash flow yield (6.13%) 0.31% (25.50%)

Profitability

Metric COGT TVTX Biotechnology median
Gross margin 0.00% 98.60% 65.16%
Operating margin 0.00% (6.84%) 0.00%
Net margin 0.00% (7.35%) 0.00%
Free cash flow margin 0.00% 2.56% 0.00%
Return on equity (146.55%) (151.79%) (56.36%)
Return on assets (68.00%) (6.42%) (48.04%)
Return on invested capital 0.00% (18.31%) 0.00%

Growth

Metric COGT TVTX Biotechnology median
Revenue growth (TTM) 110.23% 77.12% 6.02%
EPS growth (last fiscal year) (11.34%) 92.89% 30.26%
Revenue growth, 5-year CAGR 21.39% 19.87% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COGT TVTX Biotechnology median
Debt to equity 0.42 24.58 0.00
Current ratio 13.57 4.05 4.72
Net debt to EBITDA 2.04 2.27 0.96

Dividend

Metric COGT TVTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COGT TVTX Biotechnology median
Market cap 5.12b 4.98b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack